Metamaterial Technologies Inc. (MTI) and its optical filters division, Lamda Guard, announced today, February 21, that it has entered into a new agreement with leading aircraft manufacturer Airbus to validate, certify, and commercialize its laser protection product metaAIR, for aviation.
Appili Therapeutics Inc. (“Appili”), an anti-infective drug development company, announced today that it will be receiving $2,803,148 from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF).
Partnership to take Caribou Contests Globally, Introduce Minecraft for Education
Sydney, N.S. based Ubique Networks Inc. and Thorold, Ont. based Caribou Contests Inc. today announced a partnership to promote problem solving skills among students through global Minecraft and math competitions.
aioTV, an all-in-one metadata, curation, and personalization software development company, was granted a new key patent on February 9, 2017, defining a discovery interface in which OTT/web content merges with legacy linear and VOD to form one experience. It also defines the creation of video playlists from merged sources (i.e., personalized channels).
QRA Corp, an emerging leader in design verification technology, launched a new engineering tool today that can significantly reduce the cost and time required to build complex systems for the defense, aerospace, and automotive industries.
It’s not that we don’t think 80’s building trends aren’t still totally gnarly, but we’re giving a refresh to our Technology Innovation Centre.
A new study shows Nova Scotia has strong potential to develop an innovative biorefinery that produces an alternative fuel from renewable sources of fibre.
CarbonCure Technologies, one of the world’s leading CO2-utilization technology providers, today announced it was named in the prestigious 2017 Global Cleantech 100, produced by CTG (Cleantech Group).
Metamaterial Technologies Inc. (MTI) is pleased to announce Mr. Marco Goguen has joined the company’s executive team as the new Chief Financial Officer (CFO). He brings over 20 years of experience as an investment banker, private equity investor and entrepreneur.
Appili Therapeutics Inc. (“Appili”), an anti-infective drug development company, announced today that Stephen Nicolle has been appointed to its board of directors. A seasoned executive, Mr. Nicolle has led companies to deliver innovative customer value and returned over $100 million to their investors.